Cover Image
市場調查報告書

Advicenne Pharma的產品平台分析

Advicenne Pharma - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 317366
出版日期 內容資訊 英文 32 Pages
訂單完成後即時交付
價格
Back to Top
Advicenne Pharma的產品平台分析 Advicenne Pharma - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 32 Pages
簡介

Advicenne Pharma是總公司位於法國的製藥企業,正在開發針對癲癇,輕度鎮定,肌肉張力不全,腎細尿管症等神經疾病和腎臟障礙的兒童用治療藥。

本報告提供Advicenne Pharma的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Advicenne Pharma的基本資料

  • Advicenne Pharma概要
  • 主要資訊
  • 企業資料

Advicenne Pharma:R&D概要

  • 主要的治療範圍

Advicenne Pharma:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Advicenne Pharma:開發中產品概況

  • 後期階段產品開發中產品
    • 新藥登記前階段的產品/聯合治療模式
  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Advicenne Pharma:藥物簡介

  • ADV-5803
  • levetiracetam
  • ADV-6209
  • ADV-7103
  • ADV-7809
  • ADV-6208
  • ADV-6770
  • ADV-6769
  • ADV-6979

Advicenne Pharma:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Advicenne Pharma:總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07429CDB

Summary

Global Markets Direct's, 'Advicenne Pharma - Product Pipeline Review - 2015', provides an overview of the Advicenne Pharma's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Advicenne Pharma's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Advicenne Pharma including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Advicenne Pharma's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Advicenne Pharma's pipeline products

Reasons to buy

  • Evaluate Advicenne Pharma's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Advicenne Pharma in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Advicenne Pharma's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Advicenne Pharma and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Advicenne Pharma
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Advicenne Pharma and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Advicenne Pharma Snapshot
    • Advicenne Pharma Overview
    • Key Information
    • Key Facts
  • Advicenne Pharma - Research and Development Overview
    • Key Therapeutic Areas
  • Advicenne Pharma - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Advicenne Pharma - Pipeline Products Glance
    • Advicenne Pharma - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
    • Advicenne Pharma - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Advicenne Pharma - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Advicenne Pharma - Drug Profiles
    • ADV-6209
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • clobazam
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • levetiracetam
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • (potassium citrate + potassium bicarbonate)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADV-7809
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADV-6208
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADV-6770
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • tetrabenazine
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Advicenne Pharma - Pipeline Analysis
  • Advicenne Pharma - Pipeline Products by Target
  • Advicenne Pharma - Pipeline Products by Route of Administration
  • Advicenne Pharma - Pipeline Products by Molecule Type
  • Advicenne Pharma - Pipeline Products by Mechanism of Action
  • Advicenne Pharma - Dormant Projects
  • Advicenne Pharma - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Advicenne Pharma, Key Information
  • Advicenne Pharma, Key Facts
  • Advicenne Pharma - Pipeline by Indication, 2015
  • Advicenne Pharma - Pipeline by Stage of Development, 2015
  • Advicenne Pharma - Monotherapy Products in Pipeline, 2015
  • Advicenne Pharma - Combination Treatment Modalities in Pipeline, 2015
  • Advicenne Pharma - Partnered Products in Pipeline, 2015
  • Advicenne Pharma - Partnered Products/ Combination Treatment Modalities, 2015
  • Advicenne Pharma - Pre-Registration, 2015
  • Advicenne Pharma - Phase II, 2015
  • Advicenne Pharma - Phase I, 2015
  • Advicenne Pharma - Preclinical, 2015
  • Advicenne Pharma - Pipeline by Target, 2015
  • Advicenne Pharma - Pipeline by Route of Administration, 2015
  • Advicenne Pharma - Pipeline by Molecule Type, 2015
  • Advicenne Pharma - Pipeline Products by Mechanism of Action, 2015
  • Advicenne Pharma - Dormant Developmental Projects,2015
  • Advicenne Pharma, Other Locations

List of Figures

  • Advicenne Pharma - Pipeline by Top 10 Indication, 2015
  • Advicenne Pharma - Pipeline by Stage of Development, 2015
  • Advicenne Pharma - Monotherapy Products in Pipeline, 2015
  • Advicenne Pharma - Pipeline by Top 10 Target, 2015
  • Advicenne Pharma - Pipeline by Top 10 Route of Administration, 2015
  • Advicenne Pharma - Pipeline by Top 10 Molecule Type, 2015
  • Advicenne Pharma - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top